check_circleStudy Completed

Candidiasis, Vulvovaginal

Bayer Identifier:

Trial_0460

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
0460_Canesten

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

14 - 66 Years
  • -

  • -

Trial summary

Enrollment Goal
50
Trial Dates
June 1980 - Today
Phase
N/A
Could I Receive a placebo
N/A
Products
Mycelex (Clotrimazole, BAYB5097)
Accepts Healthy Volunteer
N/A

Trial design

Efficacy and tolerance of two galenical product formulations of Canesten vaginal tablets containing 500 mg of the active ingredient clotrimazole after a single administration to patients with vaginal yeast infections.
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.